ACTRN12617001623381尚未招募2 期
Effects of Resveratrol on Coagulation in Patients Undergoing Liver Resection for Cancers: a phase II double-blind randomised-controlled trial
Kwok Ming Ho0 个研究点目标入组 20 人开始时间: 2017年12月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of resveratrol on serum irisin and adiponectin in patients With type 2 diabetesType 2 Diabetes Mellitus.non-insulin-dependent-diabetes-mellitusIRCT201601022394N19Vice chancellor for research, Iran University of Medical Sciences56
招募中
3 期
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
尚未招募
3 期
Resveratrol in acute ischemic strokeAcute ischemic stroke.Cerebral infarction, unspecifiedI63.9IRCT20091114002709N61Iran University of Medical Sciences76
已完成
2 期
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50
已完成
3 期
The effect of resveratrol on diabetes treatmentType 2 diabetes.Non-insulin-dependent diabetes mellitusIRCT2015080223336N2Vice chancellor of Research, Tehran University of Medical Sciences, Dr. Masoud Younesian60